Scientist I, Nanoparticle Formulation and Process Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

GenEdit · 3 weeks ago

Scientist I, Nanoparticle Formulation and Process Development

positionSouth San Francisco, CA
timeFull-time
remoteOnsite
seniorityMid Level
date3+ years exp

GenEdit is an early-stage company that is developing a proprietary and novel delivery platform with the potential to transform genetic medicines. They are seeking a talented scientist to support the development of genetic medicines utilizing their proprietary hydrophilic nanoparticle platform, focusing on formulation activities and lab work.

BiotechnologyGeneticsPharmaceuticalTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Support the development of genetic medicines utilizing GenEdit’s proprietary hydrophilic nanoparticle (HNP) platform
Work full-time in our wet labs to support nanoparticle formulation activities
Execute at a high level in the lab
Keep detailed lab records
Execute, optimize, and develop analytical techniques
Cooperate efficiently with other technicians and scientists

Qualification

Nanoparticle formulationAnalytical characterizationProcess developmentMolecular biology techniquesExperimental designCommunication skillsOrganizational skillsPresentation skills

Required

PhD (or BS/MS with significant experience) in nanoparticle sciences and formulation
3+ years of relevant hands-on lab experience, ideally in an industry setting
expertise in nanoparticle formulation and related analytical characterization: optimization of mRNA and small molecule encapsulation mixing methods (IJM, microfluidics), light scattering and zeta potential (DLS, MALS), quantitative fluorescence assays (RiboGreen, fluorescamine)
Capable of independent experimental design, execution, and technical trouble shooting
Ability to efficiently execute in the lab, develop standard operating procedures with precise reproducibility, and maintain detailed electronic lab notebook records
Excellent communication, presentation, and organizational skills
Work authorization in the US is required

Preferred

nanoparticle scale-up manufacturing and process development including purification and concentration methods (TFF, UF/DF, sterile filtration, analytical HPLC)
standard molecular and cell biology techniques including UV-Vis, gel electrophoresis, protein expression characterization (western blot, ELISA, flow cytometry, FlowJo) and transfection of mammalian tissue culture

Company

GenEdit

twittertwitter
company-logo
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
dateFounded in 2016
location
South San Francisco, California, USA
people-size11-50 employees
web-link
http://www.genedit.com

H1B Sponsorship

GenEdit has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (1)

Funding

Current Stage
Early Stage
Total Funding
$67.72M
Key Investors
Qiming Venture PartnersEli LillyNational Science Foundation
2024-01-23Series A· $24M
2021-11-01Angel· $9M
2021-09-23Series A· $26M

Leadership Team

leader-logo
Kunwoo Lee
Co-Founder & CEO
linkedin
leader-logo
Hyo Min Park
Co-Founder & Chief Operating Officer
linkedin

Recent News

Yahoo! News
GenEdit Appoints Dr. J. Rodrigo Mora as Chief Scientific Officer to Expand Its NanoGalaxy® Genetic Medicine Platform into Immunology
2025-04-03
Pulse News Korea
GenEdit aims to expand with gene therapy - Pulse by Maeil Business News Korea
2024-05-05
Business Wire
GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles ...
2024-04-09
Company data provided by crunchbase